( AMEX:INO )

News from inovio pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 11, 2014, 08:30 ET Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million...


Aug 06, 2014, 17:16 ET INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuticals, Inc.

Levi & Korsinsky, LLP is investigating Inovio Pharmaceuticals, Inc. (NYSE: INO) in connection with possible claims of breaches of fiduciary...


Aug 01, 2014, 08:00 ET Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014 financial...


May 05, 2014, 04:00 ET Inovio Pharmaceuticals to Report First Quarter 2014 Financial Results on May 12, 2014

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its first quarter...


Apr 01, 2014, 04:00 ET Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible...


Mar 26, 2014, 04:00 ET Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was recognized with three industry awards at the World Vaccine Congress,...


Mar 17, 2014, 04:00 ET Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the fourth quarter and year ended December 31, 2013. Total...


Mar 12, 2014, 04:00 ET Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call and live webcast to report its fourth quarter...


Mar 04, 2014, 09:49 ET Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today closed its previously announced underwritten public offering of...


Feb 27, 2014, 09:00 ET Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced the pricing of an underwritten public offering of...


Feb 26, 2014, 16:01 ET Inovio Pharmaceuticals Announces Public Offering of Common Stock

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) ("Inovio" or the "Company"), today announced that it intends to offer and sell shares of its common...


Feb 19, 2014, 04:00 ET Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the...


Feb 18, 2014, 04:00 ET Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has expanded its senior management team with two appointments to help advance the...


Feb 11, 2014, 04:00 ET Inovio Pharmaceuticals Invited To Ring the Opening Bell® at the New York Stock Exchange on February 12

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it has been invited by the New York Stock Exchange to...


Jan 30, 2014, 04:00 ET Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of...


Jan 23, 2014, 04:00 ET Inovio Pharmaceuticals Unveils Potent New Immune Activator

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin...


Jan 06, 2014, 04:00 ET Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, will present a corporate overview of...


Dec 11, 2013, 08:05 ET CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel

 Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, has been invited to participate on an...